Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy

Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy

(1) Background: Pulmonary endarterectomy (PEA) is the "gold standard" treatment for operable patients with chronic thromboembolic pulmonary hypertension (CTEPH). Persistent pulmonary hypertension (PH) after PEA confers a worse prognosis. Balloon pulmonary angioplasty (BPA) could represent...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine Vol. 12; no. 3; p. 905
Main Authors: Maneiro Melon, Nicolas M, Velazquez Martin, Maite, Huertas Nieto, Sergio, Albarran Gonzalez-Trevilla, Agustin, Sarnago Cebada, Fernando, Cruz Utrilla, Alejandro, Hinojosa Camargo, Williams, Aguilar Colindres, Ricardo, Melendo Viu, Maria, Lopez Gude, Maria Jesus, Morales Ruiz, Rafael, Perez Nuñez, Marta, Arribas Ynsaurriaga, Fernando, Escribano Subias, Pilar
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 23-01-2023
MDPI
Subjects:
Angioplasty
Cardiology
Edema
Hemodynamics
Hemoptysis
Medical imaging
Mortality
Multidisciplinary teams
Normal distribution
Patients
Pulmonary hypertension
Statistical analysis
Surgery
Tomography
Variables
United States > US
chronic thromboembolic pulmonary hypertension
balloon pulmonary angioplasty
pulmonary endarterectomy
pulmonary hypertension
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(1) Background: Pulmonary endarterectomy (PEA) is the "gold standard" treatment for operable patients with chronic thromboembolic pulmonary hypertension (CTEPH). Persistent pulmonary hypertension (PH) after PEA confers a worse prognosis. Balloon pulmonary angioplasty (BPA) could represent a useful therapy in this setting, but evidence about its effectiveness and safety in patients with previous PEA is limited. (2) Methods: A total of 14 patients with persistent PH after PEA were treated with BPA in a single PH center. Hemodynamic and clinical effects of BPA and complications of the procedure were retrospectively collected. (3) Results: After BPA, the mean pulmonary arterial pressure fell from 50.7 ± 15.3 mmHg to 38.0 ± 7.9 mmHg (25.0% decrease; 95% confidence interval (CI) 14.0-35.5%; = 0.01). Pulmonary vascular resistances were reduced from 8.5 ± 3.6 WU to 5.3 ± 2.2 WU (37.6% decrease; 95% CI 18.8-56.5%; = 0.01). WHO functional class was also improved with BPA. Severe BPA-related complications were infrequent and no periprocedural deaths were observed. (4) Conclusions: BPA is an effective and safe therapy for patients with CTEPH and persistent PH after PEA.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12030905